CLINICAL, PATHOLOGIC AND GENOMIC PROFILES OF EXCEPTIONAL RESPONDERS TO ANTI-PD1 THERAPY IN RENAL CELL CARCINOMA

被引：0
|
作者：
Ball, Mark
Johnson, Michael
Gorin, Michael
Rodriguez, Maria
Zhang, Ming
Papadopoulos, Nick
Haffner, Michael
Hammers, Hans
Marchionni, Luigi
Netto, George
Drake, Charles
Allaf, Mohamad
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词：
D O I：
10.1016/j.juro.2016.02.1894
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP03-01
引用
收藏
页码：E19 / E19
页数：1
相关论文
共 50 条
  • [1] Clinical, pathologic and genomic profiles of exceptional responders to anti-PD1 therapy in renal cell carcinoma
    Ball, Mark
    Johnson, Michael
    Gorin, Michael
    Rodriguez, Maria
    Diaz, Luis
    Vogelstein, Bert
    Kinzler, Kenneth
    Papadopoulos, Nick
    Haffner, Michael
    Marchionni, Luigi
    Netto, George
    Drake, Charles
    Allaf, Mohamad
    [J]. BJU INTERNATIONAL, 2015, 116 : 3 - 3
  • [2] Clinical, pathologic, and genomic profiles of exceptional responders to anti-PD1 therapy in renal cell carcinoma.
    Ball, Mark Wayne
    Johnson, Michael Hiroshi
    Gorin, Michael A.
    Rodriguez, Maria
    Diaz, Luis A.
    Haffner, Michael
    Netto, George J.
    Drake, Charles G.
    Allaf, Mohamad E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [3] Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy
    Ikeda, Sadakatsu
    Goodman, Aaron M.
    Cohen, Philip R.
    Jensen, Taylor J.
    Ellison, Christopher K.
    Frampton, Garrett
    Miller, Vincent
    Patel, Sandip P.
    Kurzrock, Razelle
    [J]. NPJ GENOMIC MEDICINE, 2016, 1
  • [4] Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy
    Sadakatsu Ikeda
    Aaron M Goodman
    Philip R Cohen
    Taylor J Jensen
    Christopher K Ellison
    Garrett Frampton
    Vincent Miller
    Sandip P Patel
    Razelle Kurzrock
    [J]. npj Genomic Medicine, 1
  • [5] Pathologic Features of Renal Carcinoma Following Anti-PD1 Therapy. A Clinicopathologic Analysis of 12 Cases
    Samdani, Rashmi
    Rao, Priya
    [J]. MODERN PATHOLOGY, 2017, 30 : 254A - 254A
  • [6] Pathologic Features of Renal Carcinoma Following Anti-PD1 Therapy. A Clinicopathologic Analysis of 12 Cases
    Samdani, Rashmi
    Rao, Priya
    [J]. LABORATORY INVESTIGATION, 2017, 97 : 254A - 254A
  • [7] Genomic and immunohistochemical characterization of patients with advanced papillary renal cell carcinoma: Focus on exceptional responders
    Salgia, Nicholas J.
    Dizman, Nazli
    Mambetsariev, Isa
    Mirzapoiazova, Tamara
    Zhao, Dan
    Kulkarni, Prakash
    Salgia, Ravi
    Pal, Sumanta K.
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [8] Unraveling LGALS1 as a Potential Immune Checkpoint and a Predictor of the Response to Anti-PD1 Therapy in Clear Cell Renal Carcinoma
    Li, Yan
    Yang, Shouyan
    Yue, Honggang
    Yuan, Dandi
    Li, Luxia
    Zhao, Jinghong
    Zhao, Lintao
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (03) : 1451 - 1458
  • [9] Second- or Third-line Therapy for advanced Renal Cell Carcinoma after Anti-PD1/L Failure
    Rexer, Heidrun
    Banek, Severine
    Doehn, Christian
    [J]. AKTUELLE UROLOGIE, 2022, 53 (02) : 122 - 123
  • [10] Genomic characteristics of exceptional responders to treatment with PD-1 inhibitors in refractory/metastatic head and neck squamous cell carcinoma
    Chang, Mark
    Song, Alexander
    Deyo, Logan James
    Stamos, Daniel
    Bloomer, Chance H.
    Khoury, Lara M.
    Porosnicu, Mercedes
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345